UNSPSC 51162012: Budesonide/formoterol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE109. This VA Drug Class (RE109) classifies this compound as belonging to the group ANTIASTHMA, OTHER.

UNSPSC 51162012 Budesonide/formoterol is a Commodity code that shows little relevant recent activity aligned with its nominal scope. The two most recent state and local opportunities tagged to this code do not involve budesonide/formoterol procurement. Seminole County, Florida posted IFB 60459723LAS for 1,900 units of naloxone and 800 safe drug deactivation systems annually, and Hall County, Georgia issued RFQ/P #47-010 for on-site pharmacy services including a 25-medication formulary — neither of which centers on this particular combination inhaler product. The mismatch suggests that state and local procurement databases may tag opportunities with broad pharmaceutical or respiratory-care codes without matching the specific drug or formulation actually being procured.

Without solicitations specifically targeting budesonide/formoterol supply, the code does not present a clear market signal for vendors focused on this product line. The naloxone and pharmacy-services opportunities indicate that health departments and county employee-benefit programs do source pharmaceutical products, but the absence of direct budesonide/formoterol RFPs, RFQs, or IBs means prospective bidders lack recent reference bids, volume forecasts, or contracting patterns to guide pursuit strategy. Practitioners tracking this code should monitor whether future opportunities from state health departments, Medicaid agencies, or hospital systems specifically name budesonide/formoterol or inhalers as line items, or consider whether broader pharmaceutical-supply or respiratory-care codes may better reflect actual state and local buying activity in this therapeutic category.